Open access
1,244
Views
2
CrossRef citations to date
0
Altmetric
Original Article
Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn’s disease
Renske W. M. Pauwelsa Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The NetherlandsView further author information
, Sebastiaan ten Bokkel Huininka Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The Netherlandshttps://orcid.org/0000-0002-0618-3018View further author information
, Christien J. van der Woudea Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The NetherlandsView further author information
, M. Doukasb Department of Pathology, Erasmus MC, Rotterdam, The NetherlandsView further author information
, L. Oudijkb Department of Pathology, Erasmus MC, Rotterdam, The NetherlandsView further author information
& Annemarie C. de Vriesa Department of Gastroenterology and Hepatology, Erasmus MC, Rotterdam, The NetherlandsCorrespondence[email protected] [email protected]
View further author information
View further author information
Pages 980-987
|
Received 25 Jan 2023, Accepted 19 Mar 2023, Published online: 27 Mar 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.